Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Product name | Modotuximab Biosimilar - Research Grade mAb |
|---|---|
| Source | CAS 1310460-86-6 |
| Origin species | Chimeric |
| Expression system | Mammalian |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Modotuximab,DS 1024,Sym 004 (combination of modotuximab and futuximab),EGFR, ERBB1 domain III,anti-EGFR, ERBB1 domain III |
| Reference | PX-TA1305-d-100 |
| Note | For research use only. Not suitable for human use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal antibody |
Immobilized EGFR / ERBB1 / HER1, C-His, recombinant protein (cat. No. PX-P5701) at 0.5µg/mL (100µL/well) can bind Modotuximab Biosimilar - Anti-EGFR, ERBB1 domain III mAb (cat. No. PX-TA1305) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 0.5282M.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.